FLNA:BMV
Filana Therapeutics Inc
MX$Â 15.92
0.00%
(0.00) Siku 1
5 Okt, 12:05:31 GMT -6 · MXN
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya FLNA...
Mtaji wa soko
34.02M
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
MX$Â 56.00
Chini kwa wiki 52
MX$Â 15.92
Idadi ya wafanyakazi
19
Mtaji wa soko
34.02M
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
MX$Â 56.00
Chini kwa wiki 52
MX$Â 15.92
Idadi ya wafanyakazi
19
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Simply Wall Street
·
dakika 7 zilizopita
Learn Why The Bull Case For Enphase Energy (ENPH) Could Change Following India Gateway Launch
ad-hoc-news.de
·
dakika 8 zilizopita
Halozyme Therapeutics stock closed at USD 121.84, 0.49 percent below its 52-week high
The Globe and Mail
·
saa 1 iliyopita
Ethereum Dramatically Outperformed the S&P 500 in Q3. Is It Finally Time to Load Up on Ethereum?
Yahoo Finance
·
saa 8 zilizopita
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Wasifu
Filana Therapeutics, Inc. is an American pharmaceutical company based in Austin, Texas. Currently led by President and CEO Richard Barry, Filana is working on developing simufilam to treat tuberous sclerosis complex–related epilepsy. The company previously was developing simufilam as an oral-tablet drug candidate for the treatment of Alzheimer's disease. Development of simufilam was discontinued in November 2024 after it failed to show clinical benefit in phase III clinical trials.
In June 2024, the United States Department of Justice charged an advisor to Cassava Hoau-Yan Wang, with fraud over research results related to the experimental drug. Less than a month later, the president, chief executive officer and chairman of the board, Remi Barbier, resigned along with Lindsay Burns, his wife, who was the company's senior vice president and Wang's co-author. The U.S. Securities and Exchange Commission filed fraud charges in September 2024 against Barbier, Burns and Wang. The parties did not admit wrongdoing, but agreed to pay fines of the company $40 million, Barbier $175,000, Burns $85,000, and Wang $50,000. Wikipedia
Kuhusu Filana Therapeutics Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi19
Lilianzishwa1998
Makao makuuAustin, Texas, Marekani
Sekta-
Tovutipaintrials.com